MAIA Biotechnology Inc (MAIA)
3.36
+0.05
(+1.51%)
USD |
NYAM |
May 07, 16:00
3.32
-0.04
(-1.19%)
After-Hours: 20:00
MAIA Biotechnology Accounts Payable (Quarterly): 1.638M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.638M |
September 30, 2023 | 1.226M |
June 30, 2023 | 1.549M |
March 31, 2023 | 1.127M |
December 31, 2022 | 1.166M |
Date | Value |
---|---|
September 30, 2022 | 1.019M |
June 30, 2022 | 1.042M |
March 31, 2022 | 0.8951M |
December 31, 2021 | 0.9604M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.8951M
Minimum
Mar 2022
1.638M
Maximum
Dec 2023
1.180M
Average
1.127M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 3.543M |
Avid Bioservices Inc | 19.51M |
Oragenics Inc | 1.245M |
NeuBase Therapeutics Inc | 0.2586M |
Viking Therapeutics Inc | 5.225M |